How May Ramucirumab Help Improve Treatment Outcome for Patients with Gastrointestinal Cancers?

SIMPLE SUMMARY: Malignancies of the gastrointestinal (GI) tract are among the five most common cancers worldwide. Despite significant therapeutic improvements over the last decade, this group of cancers is characterized by high recurrence rates and a dismal prognosis. There is an urgent need for new...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ming-Huang, Lu, Sheng-Nan, Chen, Chien-Hung, Lin, Peng-Chan, Jiang, Jeng-Kai, D’yachkova, Yulia, Lukanowski, Mariusz, Cheng, Rebecca, Chen, Li-Tzong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306041/
https://www.ncbi.nlm.nih.gov/pubmed/34298750
http://dx.doi.org/10.3390/cancers13143536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306041/
https://www.ncbi.nlm.nih.gov/pubmed/34298750
http://dx.doi.org/10.3390/cancers13143536

Ejemplares similares